Are We on the Cusp of a New Era of Cruelty-Free Medicines?
Read here
We are rescuing dogs from Ridglan Farms because the FDA Modernization Act 2.0 enabled it
Read here
A Beagle Breakthrough
Read here
Progress on Animal Testing But Major Battles Loom
Read here
A Berlin Wall Moment on Animal Testing?
Read here

Latest News

Urge Congress

to end taxpayer-funded dog and cat experiments
Here

The current state at FDA

Outdated Regulations

FDA must initiate rulemaking so outdated regulations comport with the revised statute and Congressional intent.

Deliberate Ambiguity at FDA

Current FDA programs to evaluate and accept nonanimal test methods are vague, ineffective, top-heavy, and lack transparency, failing to set up the agency or drug developers for success. FDA must end its deliberate ambiguity practice regarding the use of animals in preclinical research.

the path forward

Regulatory Clarity

FDA must create a clear pathway for regulatory acceptance of nonanimal test methods.

Break the status quo

FDA must act expeditiously to change the drug development paradigm as Congress intended. Otherwise, the 90 to 95% failure rate in clinical trials of drugs that pass animal tests for safety and efficacy fail in human trials will continue.